COLGATE PALMOLIVE CO annual report, Q4 FY2008

Colgate-Palmolive Company 2008 Annual Report (10-K) Summary

Business Context and Reporting Period

This filing covers the fiscal year ended December 31, 2008. Colgate-Palmolive is a leading global consumer products company operating in over 200 countries. The business is organized into two primary segments: Oral, Personal and Home Care (86% of sales) and Pet Nutrition (14% of sales). The company employs approximately 36,600 people and operates roughly 325 properties worldwide.

Key Financial Metrics

Metric 2008 2007 Change
Net Sales $15,329.9 million $13,789.7 million +11.0%
Operating Profit $3,020.7 million $2,653.1 million +14.0%
Net Income $1,957.2 million $1,737.4 million +12.7%
Diluted EPS $3.66 $3.20 +14.4%
Gross Profit Margin 56.3% 56.2% +0.1%
Operating Margin 19.7% 19.2% +0.5%
Free Cash Flow (Approx.) $1,554.8 million $1,620.6 million -4.1%
Total Debt $3,783.5 million $3,515.9 million +7.6%
Cash & Equivalents $554.9 million $428.7 million +29.4%

Note: Free Cash Flow calculated as Net Cash Provided by Operations ($2,238.3M) less Capital Expenditures ($683.5M).

Material Changes vs. Prior Period

  • Sales Growth Drivers: Worldwide net sales increased 11.0%, driven by volume growth of 3.5%, net selling price increases of 5.5%, and a positive foreign exchange impact of 2.0%. Organic sales grew 9.5%.
  • Segment Performance:
    • Oral, Personal and Home Care: Sales up 10.5% to $13.18 billion. Latin America was the strongest region with 17.0% sales growth.
    • Pet Nutrition: Sales up 15.5% to $2.15 billion, driven by price increases of 10.5% and volume growth of 2.5%.
  • Restructuring Finalization: The company finalized its four-year "2004 Restructuring Program" in 2008. Total cumulative pretax charges for the program reached $1,069.2 million. Charges in 2008 were $163.8 million, down from $258.5 million in 2007.
  • Cost Pressures: Gross profit margin remained stable despite increases in raw and packaging material costs, which were partially offset by higher pricing and cost-savings initiatives.

Guidance, Outlook, and Risks

  • 2009 Outlook: Management expects global macroeconomic and market conditions to remain "highly challenging" in 2009. A strengthening U.S. dollar is expected to negatively impact results, though the company aims to offset this through cost declines and price increases.
  • Capital Allocation: Capital expenditures for 2009 are expected to remain consistent at approximately 4.5% of net sales. The company intends to continue paying increasing annual dividends and repurchasing shares under a new 30-million share program authorized in January 2008.
  • Key Risks:
    • Global Credit Crisis: Potential disruption in credit markets could affect financing costs and supplier/customer stability.
    • Commodity Prices: Volatility in raw materials (resins, tallow, corn, soybeans) impacts margins.
    • Legal Proceedings: Ongoing investigations into potential competition law violations in Europe (including a proposed $5 million fine in Switzerland) and significant tax disputes in Brazil (approx. $97 million exposure) and Mexico.

Investor Verification Checklist

  • Restructuring Savings: Verify the realization of the estimated $475-$500 million in annual pretax savings from the finalized 2004 Restructuring Program.
  • Foreign Exchange Exposure: Monitor the impact of the strengthening U.S. dollar on 2009 earnings, given that ~75% of sales are outside the U.S.
  • Legal Contingencies: Track the status of the Brazilian tax assessments (~$97 million) and European competition law investigations, which could result in significant fines.
  • Commodity Hedging: Review the effectiveness of hedging strategies against rising raw material costs in the context of the 2009 economic downturn.
  • Share Repurchases: Confirm the execution of the new 30-million share repurchase program and its impact on earnings per share.